Where does Thync Global, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Thync Global, Inc. ranks #15,001 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Thync Global, Inc. hold?

Thync Global, Inc. holds 20 US utility patents granted between 2016 and 2025, spanning 4 technology areas.

What is Thync Global, Inc.'s Innovation Score?

Thync Global, Inc. has an Innovation Score of 31.7 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Thync Global, Inc. focus on?

Thync Global, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 18 patents, ranking #202 of 1,943 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Thync Global, Inc.'s patent grant rate increasing or decreasing?

Thync Global, Inc.'s recent grant velocity is -36% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Thync Global, Inc.'s patents?

Thync Global, Inc.'s patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Thync Global, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Thync Global, Inc.

USPTO PatentsView assignee record - 20 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Thync ranks #15,001 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 4 technology areas.

#15,001
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.7/100): 19.4
avg claims per patent: -36%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15001 · US Corporation #15,001 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #15,001/49,997
PHOTO-FINISH The J David…
CPC-NARROW A61N · 4 areas
INNOV-THIN 31.7/100
CLAIMS-RICH 19.4 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -36% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: The J. David Gladstone Institute, a testamentary trust established under the Will of J. David Gladstone (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Thync’s 31.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (33%) Velocity 2.5 pts (8%) Breadth 7.1 pts (22%) Claim depth 11.6 pts (37%)

Qualcomm Incorporated · highest

85
Thync Global · this assignee

32
3D Lighting… · lowest

7

What this shows Thync's Innovation Score is 31.7/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Thync?

Each dot is one of Thync’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Thync’s own 19.4 claims/patent is ABOVE the 12.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Thync vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Thync's grants concentrate

Thync Global, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 90% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2018. By volume, Thync sits between The J. David Gladstone Institute, a testamentary trust established under the Will of J. David Gladstone and Toly Management Ltd..

Thync's three-year grant acceleration

Thync Global, Inc. shows 3 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

The J David Glads…

20
The L D Kichler

20
The Tomorrow Comp…

20
The United States…

20
Tigerconnect

20
Todolivo S L

20
Tokai Carbon Korea

20
Toly Management

20
Thync Global ◀

20

What this shows Thync holds 20 patents at rank #15,004, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Thync

By rank, the assignees closest to #15,004 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Thync's primary technology class.

Thync's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Thync Global, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	20.0%
2017	2	10.0%
2018	1	5.0%
2019	4	20.0%
2020	3	15.0%
2021	1	5.0%
2022	2	10.0%
2023	1	5.0%
2025partial year	2	10.0%

Which technologies does Thync Global, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 18

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

A61B - DIAGNOSIS; SURGERY; Identification 1

G10L - Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Thync Global, Inc.'s patent record in context - here's where to go next.

Thync Global, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 90% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #15,001 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Thync Global, Inc. against The J. David Gladstone Institute, a testamentary trust established under the Will of J. David Gladstone, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.